In this study, chemically synthesized magnetite was produced where the size was found to be size between 50 and 60nm with para ferro magnetic property. Coreshell magnetite nanoparticles was produced with initial coating of rifampicin by ultrasonication and was encapsulated with any of one among four different biopolymers namely chitosan, starch, casein and polyhydroxybutyrate (PHB). Coreshell nanoparticles were analysed for their drug loading efficiency and drug release studies. PHB and chitosan loaded particles were observed to release drug steadily. All the biopolymer coated nanoparticles were subjected to antibacterial activity against Klebsiella sp by agar well diffusion method. PHB and chitosan coating of the particles were found to be the best for holding rifampicin. Magnetite was subjected for MTT based cytotoxicity assay against peripheral mononuclear cells and its LC50 was found at 60 µg/ml.
INTRODUCTION
Nanotechnology is currently trending and is being extensively researched due to their optical, magnetic, bioimaging 1 , electrical properties 2 and many more, obtained due to its large surface area to volume ratio. In this broad spectrum of nanotechnology, magnetic nanoparticles, especially iron oxide nanoparticles have attracted a lot interest within the researchers due to its wide range of uses in different fields such as its role as contrasting agents in magnetic resonance imaging (MRI) 3 , magnetocaloric pumps 4 , agriculture 5 , magnet mediated cell separation and purification 6 , magnetically guided drug delivery, magnetocytolysis 7 , hyperthermia 8, 9 , environmental remediation 10 , stem cell labelling and tracking agents 11, 12 , chemotherapy 13 etc. Iron oxide nanoparticles include a wide range of oxides such as magnetite (Fe 3 O 4 ), hematite (α-Fe 2 O 3 ), maghemite (γ-Fe 2 O 3 ) and other ferrites 14 . Among the available iron oxide nanoparticles, magnetite nanoparticles are extensively used due to their super paramagnetic quality and biocompatibility 15 . Although MNPs have many uses, the main challenges faced by researches working with magnetite NPs include, stability 16 , maintenance of crystallinity of the particles etc. Targeted drug delivery using magnetite makes way for drug delivery at site as well as reduced side effects with controlled release of drug for prolonged time 17 . Magnetite nanoparticles coated with polymers have been used to carry doxorubicin and 5-fluorouracil and also evaluated in vitro [18] [19] [20] . For best performance, particles must be moderate sized, spherical, crystalline, biocompatible, superparamagnetic and should render large surface areas for tagging drugs 21 . Biopolymer coating of the magnetite nanoparticles provide them stability and also allow sustained and targeted delivery possible with less toxicity and higher biocompatibility. In this study, magnetite nanoparticles were chemically synthesized, coated with drug (rifampicin) and encapsulated with different biopolymers like casein, chitosan, starch and polyhydroxybutyrate (PHB) to hold the drug coated magnetite nanoparticles. The produced coreshell nanoparticles were subjected for different studies such as drug encapsulation efficiency, drug release kinetics and in vitro drug release studies against microbes.
MATERIALS AND METHODS

Chemicals used
Polyhydroxybutyrate (PHB) was purchased from Sigma Aldrich, India. NaOH, FeCl 3 .6H 2 O and FeSO 4 .7H 2 O were bought from Spectrum chemicals, India. Mueller Hinton agar, HiSep, dialysis tube, RPMI 1640 and MTT were purchased from HiMedia, India, where other chemicals were bought from Qualigens, India.
Chemical method of preparation of magnetite
Synthesis of magnetite nanoparticles was done through chemical co-precipitation method of Mascolo et al., 22 with some modifications. 2.14 g each of FeSO 4 .7H 2 O and FeCl 3 .6H 2 O was weighed and dissolved separately in 25 ml nitrogenated MilliQ water. Both the solutions were mixed together and made into precursor iron source solution. 50 ml of 5M NaOH solution (using Milli-Q) was added dropwise to the iron source solution under continuous vigorous manual stirring. The solution was left undisturbed in room temperature for 45 minutes. The whole solution was filtered using Whatmann no.1 filter and the obtained filtrate was separated using a magnet and washed five times with deionised water in order to bring the pH to a neutral scale. The obtained pellet was dried in hot air oven at 160 0 C. Nanoparticles were obtained as powder.
Characterization of magnetite
Magnetite nanoparticles were subjected for FeSEM-EDX (Carl Zeiss Supra 55, Germany) in order to determine the size. Magnetic property of produced nanoparticles was analysed with Vibrating Sample Magnetometer (Lakeshore, USA, Model 7407). In order to determine the crystalline nature and the form of iron oxide, X-Ray diffraction (Rigaku) was performed.
Coreshell production
10 ml of distilled water was taken in two test tubes. 0.1% acetic acid in 10 ml distilled water was taken in another two test tubes. 10 mg of antibiotic rifampicin was added to all the tubes and sonicated for 30 min. at room temperature. 1 mg of starch and casein was added separately to test tubes containing 10 ml distilled water, whereas 1 mg chitosan and polyhydroxybutyrate (PHB) was added into the test tubes containing 0.1% acetic acid (to dissolve chitosan and PHB). 1 mg of magnetic nanoparticles was added to all the tubes. All the tubes were again subjected for ultrasonication for an hour at room temperature. Then, the solution was centrifuged and the obtained pellet was lyophilized.
Characterization of Coreshell
The coreshell was subjected to Fourier Transform Infra-Red Spectroscopy (FTIR) Analysis (Shimadzu, Japan) and Scanning electron microscopy analysis (Carl Zeiss Supra 55, Germany).
Drug encapsulation efficiency
Immediately after encapsulation of drug by ultrasonication, the entire solution was taken and centrifuged. 0.5 ml supernatant was collected and the tube was slowly shaken to disperse the nanoparticles. After every 10 th min. the sample was centrifuged at 5000 g and 0.5 ml sample was collected. The above said procedure was followed till 80 th minute. The collected supernatant were read at 460nm (λmax of rifampicin) using UV Spectrophotometer (Systronics). 23, 24 A graph with time interval in x axis and absorbance in y axis was plotted using the obtained absorbance values.
In vitro drug release kinetics
Coreshell nanoparticles were subjected for drug release studies by dialysis membrane technique. 25 Each biopolymer encapsulated particles (10 mg) were taken in dialysis membranes (HiMedia, India). The tied dialysis membranes were introduced to a beaker containing 50 ml PBS solution (phosphate buffer solution -pH 6.8). PHB coated nanoparticles containing dialysis bag was immersed into 50 ml acidified PBS (pH 6.4 -made to this pH by adding acetic acid to it). This was done to dissolve PHB in acidic pH and to release the drug. 1 ml of sample was collected from the beaker at every 15 th min. time interval for 3 h and subjected for absorbance at 460nm in UV -Visible Spectrophotometer (Systronics). A graph with time interval in x axis and absorbance in y axis was plotted.
Anti-Bacterial activity
In vitro drug release studies and bactericidal activity for coreshell nanoparticles was done against Klebsiella sp. by agar well diffusion method. 26 Mueller Hinton agar plate was swabbed all over with Klebsiella sp. Wells were made using gel punching kit. Particles were dispersed in PBS and different concentrations of particles (10 µg, 20 µg, 30 µg and 40 µg) were poured onto the wells. After 48 h, the zone of clearance was measured and recorded.
MTT based cytotoxicity assay Isolation of peripheral Blood Mononuclear Cells (pBMC) 27 2ml of intravenous blood sample was collected and transferred to a tube containing EDTA. Blood was added with 2 ml of RPMI 1640 media (without serum). It was carefully overlaid on lymphocyte separation solution (HiSep) (HiMedia, India) and centrifuged at 8000 rpm for 10 minutes. The interphase of the content was collected and added to RPMI 1640 (without serum) and centrifuged again at 8000 rpm for 10 min. to the obtained pellet, 1 ml of RPMI 1640 (with 10% serum) was added and this consisted of PBMC.
MTT ASSAY28
The PBMC suspension was diluted with RPMI 1640 (with 10% serum) (HiMedia, India) in order to get 1 X 10³ cells/ 20 µl suspension. These cells were then added to 96 well tissue culture plate. The content was made upto 100 µl using RPMI 1640 (with 10% serum). The 96 well plate was covered and incubated in a humidified atmosphere at 37 o C for 3 h in 5% CO 2 incubator to make the cells to adapt to the condition. After the incubation time, the nanoparticles were dispersed in RPMI 1640 medium (with 10% serum) and were treated with different concentrations of core-shell nanoparticles (i.e., 20, 40, 60 and 80 µg). Every well was made upto 200 µl using fresh medium and was incubated for 24 hours. After incubation, 15 µl MTT (5 mg/ml) was added to all wells and were incubated for 4 h in CO 2 incubator at 37 o C. The contents of the well were aspirated and 200 µl of DMSO was added. The absorbance was recorded at 570 nm. The graph was plotted with percentage cytotoxicity (Y-axis) against the concentration of drug (X-axis).
Percentage cytotoxicity was calculated by the following formula,
RESULT AND DISCUSSION
Characterization of magnetite
The size of the nanoparticles as per the Fe-SEM analysis was found to be between 50 nm and 60 nm while, the chemical composition of the synthesized particles were found to have Fe 3+ and O 4 in it using EDX analysis (Fig. 1) . Nanoparticles of size below 100 nm are suitable for drug delivery or drug carrier [29] [30] [31] , thus the produced magnetite can be used to form core shell nanoparticles for drug delivery. M agnetite nanopar ticles were found to possess para-ferromagnetic activity by VSM (Vibrating Sample Magnetometer) analysis (Fig. 2) . The saturation magnetization of Fe 3 O 4 particles at 2500 G were found to be 2.4 emu/g, which are in good agreement with magnetic data reported on magnetite. Varma et al., 32 reported the saturation magnetization of chemically synthesised Fe 3 O 4 particles at 8000 G was found to be 2.4 emu/g. Very lower i.e. ~50 emu/g was reported in MC-IOPs by Bhattarai et al.,(2008) 33 .
The peaks formed found by XRD analysis were indexed to (220), (311), (400), (511) indicating the characteristic graph of cubic crystalline structure of magnetite nanoparticles (Fe 3 O 4 ) (Fig. 3) , which is on par with the earlier reports 22, 34, 35 .
Characterization of Coreshell nanoparticles
FTIR spectra of magnetite nanoparticles showed an IR band at 3356 cm -1 and 2900 cm -1 which is for O-stretching mode. IR band at 1629 cm -1 was due to H 2 O bending vibrations. The FT-IR spectrum of substoichiometric magnetite Fe 3 O 4 showed two IR bands at 507 and 474 cm -1 . Thus, the produced magnetite has found to be having the chemical formula of Fe 3 O 4 (Fig. 4a) . IR bands at 565 and 360 cm -1 were reported for vibration modes in Fe 3 O 4 [36] [37] [38] . Absorption bands of chitosan was observed at 3360 cm -1 which depicted the O-H and N-H stretching vibrations. The other peaks such as ∼2800 cm -1 (C-H), 1653 cm -1 (N-H), and 1080 cm −1 (C-O-C) were also the characteristics of chitosan (Fig. 4b ) [39] [40] [41] . IR spectra of PHB showed the bands at 1100 and 1273 cm -1 representing C-O-C while band at 1380 cm -1 represents -CH 3 and the band at 1641 cm -1 for C=O stretching of ester carbonyl group (Fig. 4c) 
42
.
In casein encapsulated particles 1544-1527 cm -1 , for N-H bending vibrations of amide and 1641 cm -1 for C=O stretch of peptide bond (Fig. 4d) 
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. Bands between 850 and 500 cm -1 for C-C stretching and C-H bending were for anhydroglucose unit of starch. The peak near 1000 cm -1 corresponds to -C-O-Cbonds while the peaks at 2650 cm -1 and ∼3300 cm -1 were due to the characteristic vibrations of C-H and -OH bonds (Figure 4e ) 44 .
When the magnetite was subjected for coreshell formation i.e coating with antibacterial agent (rifampicin) and biopolymer, the size of the particle was found to increase as studied through SEM analysis, where it was higher with chitosan coating (Fig. 5a) . Amongst all the biopolymer used, polyhydroxyalkonate coated nanoparticles were found to be smaller in size (80-90nm) Figure 5b .
Drug encapsulation efficiency
All the biopolymers could encapsulate the drug in less than 30 min. (Fig. 6 ). It might be because the drug and biopolymer coating were subjected for 1 h of sonication, whereas Márquez et al., found that SiO 2 -magnetite microspheres took 9 h of contact time when being coated with 0.413 mg Rhodamine B and 0.343 mg methotrexate at 40°C 45 . In vitro drug release kinetics PHB and chitosan were found to release drug slowly and steadily for 3 h (Fig. 7) , other polymers such as casein and starch was releasing faster since they got solubilized in water. Hence, PHB and Chitosan biopolymers were found to be good encapsulating agents as they release slowly and efficiently. Samrot et al., 46 also reported chitosan based microparticles to release curcumin for 3 hours. Magnetic-chitosan nanogels have also been reported to release doxorubicin over 72 hours 47 . 
Antimicrobial activity
Among all the biopolymers used in this study, chitosan and PHA were found to be the best for holding the antibacterial compound i.e. rifampicin (Table 1) . Chitosan coated particles were not showing antibacterial activity since the organism lacks enzymes to degrade chitosan, but PHA might have been utilized by Klebsiella sp, as it might possess enzyme like depolymerases to degrade PHA48. Casein and starch coated particles were showing uneven results, which might be due to solubilizing nature in water. 
Cytotoxicity assay
Magnetite nanoparticles were found to have LC50 at 60 µg/ml concentration against the normal blood cells i.e. peripheral blood mononuclear cells. Thus, the concentration below 60 µg/ml could be used for the drug delivering study invitro (Fig. 8) . It has been noticed that magnetic nanoparticles are not affecting cell viability, proliferation, or differentiation capacity of stem cells and few studies were only there to report adverse or toxic effects of magnetite nanoparticles 49, 50 . 
CONCLUSION
Magnetite was produced by chemical co-precipitation method and the size of the nanoparticle was found to be between 50 and 60 nm. The coreshell nanoparticle was produced by coating magnetite nanoparticles with antibiotic -rifampicin and encapsulated with biopolymers like chitosan, PHB, starch and casein. Both the chitosan and PHB coated particles were found to show a slow and steady release of drug. Antibacterial activity of the coreshell particles was assessed using Klebsiella sp where, PHB showed a stable zone of inhibition around the well whereas, chitosan did not release any drug as there was no zone of inhibition. LC50 value of the produced nanoparticles was found to be 60 µg/ml against PBMC cells.
